Abstract
Patients with liver cirrhosis (LC) have impaired immunity and are, thus, predisposed to infection. Few studies have attempted to evaluate group B streptococcal (GBS) bacteremia in LC patients. A retrospective study of patients with GBS bacteremia was performed at the Dongguk University Ilsan Hospital and National Health Insurance Service Ilsan Hospital over a 13-year period (October 2000 to July 2013). During the study period, 97 patients with GBS bacteremia were enrolled. The median age of the patients was 67 years and 54 % were men. Among them, 23 (24 %) patients were classified as LC patients. The 30-day mortality rate of LC patients was significantly higher than that of patients with other diseases (26 % vs. 8 %, p = 0.03). The multivariate analysis indicated that LC was associated with an increased risk of 30-day mortality [hazard ratio (HR) 5.0; 95 % confidence interval (CI) 1.53–16.3; p = 0.008], as well as age (HR 1.07; 95 % CI 1.03–1.13; p = 0.02) and high Pitt bacteremia score (HR 1.23; 95 % CI 1.02–1.46; p = 0.03). The probability of survival at day 30 was significantly different for the Child–Pugh class C and the Child–Pugh classes A or B (44 % vs. 93 %, respectively; p = 0.01 by the log-rank test). The mortality rates of LC patients with GBS bacteremia were significantly higher than those of patients with other diseases. The severity of hepatic dysfunction plays an important role in the development of adverse events. Cirrhosis-specific scores such as the Child–Pugh class might be useful for predicting the prognosis of GBS bacteremia in LC patients.
Similar content being viewed by others
References
Zangwill KM, Schuchat A, Wenger JD (1992) Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. MMWR CDC Surveill Summ 41(6):25–32
Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K et al (2009) Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990–2007. Clin Infect Dis 49(1):85–92
Jackson LA, Hilsdon R, Farley MM, Harrison LH, Reingold AL, Plikaytis BD et al (1995) Risk factors for group B streptococcal disease in adults. Ann Intern Med 123(6):415–420
Christou L, Pappas G, Falagas ME (2007) Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol 102(7):1510–1517
Cho SY, Kang CI, Kim J, Joo EJ, Ha YE, Chung DR et al (2013) Association of liver cirrhosis with group B streptococcal bacteremia in non-pregnant adults. J Infect 67(6):617–619
Huang PY, Lee MH, Yang CC, Leu HS (2006) Group B streptococcal bacteremia in non-pregnant adults. J Microbiol Immunol Infect 39(3):237–241
Kim BN, Bae IG, Kim MN, Woo JH, Ryu J, Kim YS (2001) Group B streptococcal bacteremia in nonpregnant adults with hepatic disease in Korea. Eur J Clin Microbiol Infect Dis 20(9):639–642
Terra C, Guevara M, Torre A, Gilabert R, Fernández J, Martín-Llahí M et al (2005) Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterology 129(6):1944–1953
Durand F, Valla D (2008) Assessment of prognosis of cirrhosis. Semin Liver Dis 28(1):110–122
Park HJ, Lee YM, Bang KM, Park SY, Moon SM, Park KH et al (2012) Clinical significance of Staphylococcus aureus bacteremia in patients with liver cirrhosis. Eur J Clin Microbiol Infect Dis 31(12):3309–3316
Viasus D, Garcia-Vidal C, Castellote J, Adamuz J, Verdaguer R, Dorca J et al (2011) Community-acquired pneumonia in patients with liver cirrhosis: clinical features, outcomes, and usefulness of severity scores. Medicine (Baltimore) 90(2):110–118
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383
McCabe WR, Jackson GG (1962) Gram-negative bacteremia: I. Etiology and ecology. Arch Intern Med 110(6):847–855
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20(6):864–874
Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H et al (2004) International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med 140(1):26–32
Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP et al (2002) Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137(10):791–797
Campillo B, Richardet JP, Kheo T, Dupeyron C (2002) Nosocomial spontaneous bacterial peritonitis and bacteremia in cirrhotic patients: impact of isolate type on prognosis and characteristics of infection. Clin Infect Dis 35(1):1–10
Infante-Rivard C, Esnaola S, Villeneuve JP (1987) Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology 7(4):660–664
Kang CI, Song JH, Chung DR, Peck KR, Yeom JS, Ki HK et al (2011) Liver cirrhosis as a risk factor for mortality in a national cohort of patients with bacteremia. J Infect 63(5):336–343
Chen SY, Tsai CL, Lin CH, Lee CC, Chiang WC, Wang JL et al (2009) Impact of liver cirrhosis on mortality in patients with community-acquired bacteremia. Diagn Microbiol Infect Dis 64(2):124–130
Graudal N, Hubeck B, Bonde J, Thomsen AC (1987) The prognostic significance of bacteremia in hepatic cirrhosis. Liver 7(3):138–141
Schuppan D, Afdhal NH (2008) Liver cirrhosis. Lancet 371(9615):838–851
Mackenzie I, Woodhouse J (2006) C-reactive protein concentrations during bacteraemia: a comparison between patients with and without liver dysfunction. Intensive Care Med 32(9):1344–1351
Edwards MS, Baker CJ (2005) Group B streptococcal infections in elderly adults. Clin Infect Dis 41(6):839–847
Larppanichpoonphol P, Watanakunakorn C (2001) Group B streptococcal bacteremia in nonpregnant adults at a community teaching hospital. South Med J 94(12):1206–1211
Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB et al (2000) Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 342(1):15–20
Conflict of interest
All authors declare that they have no conflicts of interest.
Financial support
This work was supported by the Dongguk University Research Fund of 2012.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Park, S.Y., Park, Y., Chung, JW. et al. Group B streptococcal bacteremia in non-pregnant adults: results from two Korean centers. Eur J Clin Microbiol Infect Dis 33, 1785–1790 (2014). https://doi.org/10.1007/s10096-014-2140-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-014-2140-9